The global hemostats and tissue sealants market is anticipated to grow at a CAGR of 8.03% between 2019 and 2027. Hemostats and tissue sealants are used post-surgery or after traumatic injuries to bind or hold external tissue (skin) as well as internal tissue (blood vessels). The hemostats and sealants market is primarily driven by the following factors:

• Increasing incidence of chronic diseases
• Increase in aging population
• Increase in the number of surgeries

To know more about this report, request a free sample copy

The important drivers that are increasing the growth of the global hemostats and sealants market are the increasing cases of chronic diseases and the surge in the geriatric population. With the worldwide rise in the commonness of chronic conditions, the volume of surgical procedures is expected to increase. This is further expected to drive the demand for wound healing and sealants. Increase in aging population, which is prone to cardiovascular, neurological and musculoskeletal diseases, is expected to propel the growth of hemostasis and tissue sealing market over the forecast period.

The products of hemostats and sealants market are used extensively for various purposes. Topical hemostats are further classified into mechanical, active and flowable hemostats. Topical hemostats are generally used along with conventional treatment procedures to provide minimal tissue reactivity, quick & easy absorbability of the hemostatic agent, non-antigenicity and cost-efficiency. Mechanical hemostats perform coagulation by passively being in contact with the injured region. Active hemostats provide for controlled bleeding, better than that of the passive agents and are capable of achieving hemostasis within approximately 10 minutes. Flowable hemostats are an amalgamation of mechanical and active agents. Adhesive and tissue sealants play a prominent role in controlling blood loss during surgeries. Synthetic tissue sealants are further divided into oxidized regenerated cellulose, cyanoacrylate adhesives and other synthetic tissue sealants. Natural tissue sealants comprise of fibrin sealants, albumin sealants and collagen-based sealants.

Stringent regulations, adverse reactions and complications are the major factors hindering the growth of the hemostats and sealants market. Adverse reactions and complications can worsen a patient’s condition, so to avoid that they need to undergo an extensive agency review. It is a major constraint for the hemostasis and tissue sealing agents market.

The global hemostats and sealants market segmented into products.

Products are sub-segmented into:

• Topical hemostat
  • Mechanical hemostats
  • Active hemostats
  • Flowable hemostats
• Adhesive and tissue sealants
  • Synthetic tissue sealant
  • Oxidized regenerated cellulose
  • Cyanoacrylate adhesives
  • Other synthetic tissue sealants
  • Natural tissue sealant
  • Chitin and chitosan-based hemostatic agent
  • Other natural tissue sealant
  • Adhesion barrier products

This report covered the present market conditions and the growth prospects of the global hemostats and sealants market for the forecast years of 2019-2027 and considered the revenue generated through the sales of hemostats and sealants for products to calculate the market size by considering 2018 as the base year.

Geographically, the global hemostats and sealants market has been segmented on the basis of four major regions, which include:

• Hemostats and Tissue Sealants North America Market: The United States & Canada
• Hemostats and Tissue Sealants Asia Pacific Market: China, India, Japan, Australia, South Korea & Rest of APAC
• Hemostats and Tissue Sealants Europe Market: The United Kingdom, France, Germany, Spain, Italy & Rest of Europe
• Rest of World: Latin America & the Middle East and Africa

The hemostats and sealants market in North America is expected to hold the largest share by 2027, and there are possibilities of aggressive marketing of such devices in this region. Other factors responsible for the market growth are the regular launch of new products, increasing applications of such devices in surgeries and other medical fields, and growing demand for tissue sealing agents that minimize post-operative complications and increase the speed of healing.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the hemostats and sealants market. Major factors boosting this regional market are increasing governmental initiatives that promote the use of such medical devices, growing geriatric population and increasing healthcare expenditure. Japan is estimated to be the country having the largest market share in 2018 in the Asia Pacific region. Major factors responsible for this particular market growth are growing awareness about the usage of such medical devices to avoid thrombosis and other critical post-operative complications, development of healthcare infrastructure and increasing healthcare expenditure.

The major market players of the global hemostats and sealants market are:

• Johnson And Johnson
• Cryolife Inc.
• Advanced Medical Solutions (AMS) Group PLC
• R. Bard, Inc.
• Pfizer, Inc.

Johnson & Johnson is a worldwide producer of health care products as well as a provider of associated services. It has major operations in the Europe, Americas, Asia Pacific and Africa. The company operates through three segments: pharmaceutical, medical devices and consumer. Pfizer Inc. (Pfizer or ‘the company’), a global biopharmaceutical company, is engaged in the discovery, development and manufacture of healthcare products. The company operates in the US, Europe, Asia, Latin America, the Middle East, Africa, Australia, Canada, Japan, New Zealand and South Korea.

Key Findings of the global hemostats and sealants market:

• Topical hemostat holds the largest market share and is anticipated to grow at the faster rate during the forecast period
• Synthetic tissue sealants of the adhesive and tissue sealants hold the largest market share